Publications
131 results found
Trepel M, Stoneham CA, Eleftherohorinou H, et al., 2009, A heterotypic bystander effect for tumor cell killing after adeno-associated virus/phage-mediated, vascular-targeted suicide gene transfer, MOLECULAR CANCER THERAPEUTICS, Vol: 8, Pages: 2383-2391, ISSN: 1535-7163
- Author Web Link
- Cite
- Citations: 46
Jarraya B, Ralph S, Lepetit H, et al., 2009, A Phase I/II Trial for Parkinson's Disease Using a Lentiviral Vector (ProSavin®), 12th Annual Meeting of the American Society of Gene Therapy, Publisher: NATURE PUBLISHING GROUP, Pages: S197-S197, ISSN: 1525-0016
- Author Web Link
- Cite
- Citations: 1
Trepel M, Stoneham CA, Mazarakis ND, et al., 2009, A Heterotypic Bystander Effect Observed for Tumor Cell Killing after AAVP-Mediated Vascular-Targeted Suicide Gene Transfer, 12th Annual Meeting of the American Society of Gene Therapy, Publisher: NATURE PUBLISHING GROUP, Pages: S108-S108, ISSN: 1525-0016
De Belleroche JS, Mitchell J, Paul P, et al., 2009, A Novel Putative Familial ALS Locus on Chromosome 12: D-Amino Acid Oxidase, 61st Annual Meeting of American-Academy-of-Neurology, Publisher: LIPPINCOTT WILLIAMS & WILKINS, Pages: A114-A114, ISSN: 0028-3878
- Author Web Link
- Cite
- Citations: 1
Jarraya B, Ralph S, Lepetit H, et al., 2008, ProSavin: A gene therapy for Parkinson's Disease, 16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Publisher: MARY ANN LIEBERT INC, Pages: 1060-1061, ISSN: 1043-0342
Jarraya B, Ralph S, Bonvento G, et al., 2007, Lentiviral-mediated dopamine replacement mediates sustained correction of parkinsonian symptoms in an MPTP-lesioned NHP model, 15th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Publisher: MARY ANN LIEBERT INC, Pages: 1026-1026, ISSN: 1043-0342
Yip PK, Wong L-F, Pattinson D, et al., 2006, Lentiviral vector expressing retinoic acid receptor β2 promotes recovery of function after corticospinal tract injury in the adult rat spinal cord, HUMAN MOLECULAR GENETICS, Vol: 15, Pages: 3107-3118, ISSN: 0964-6906
- Author Web Link
- Cite
- Citations: 62
So P-L, Yip PK, Bunting S, et al., 2006, Interactions between retinoic acid, nerve growth factor and sonic hedgehog signalling pathways in neurite outgrowth, DEVELOPMENTAL BIOLOGY, Vol: 298, Pages: 167-175, ISSN: 0012-1606
- Author Web Link
- Cite
- Citations: 32
Pezet S, Krzyzanowska A, Wong L-F, et al., 2006, Reversal of neurochemical changes and pain-related behavior in a model of neuropathic pain using modified lentiviral vectors expressing GDNF, MOLECULAR THERAPY, Vol: 13, Pages: 1101-1109, ISSN: 1525-0016
- Author Web Link
- Cite
- Citations: 54
Wong LF, Yip PK, Battaglia A, et al., 2006, Retinoic acid receptor β2 promotes functional regeneration of sensory axons in the spinal cord, NATURE NEUROSCIENCE, Vol: 9, Pages: 243-250, ISSN: 1097-6256
- Author Web Link
- Cite
- Citations: 104
Wong LF, Goodhead L, Prat C, et al., 2006, Lentivirus-mediated gene transfer to the central nervous system: Therapeutic and research applications, HUMAN GENE THERAPY, Vol: 17, Pages: 1-9, ISSN: 1043-0342
- Author Web Link
- Cite
- Citations: 131
Ralph GS, Binley K, Wong LF, et al., 2006, Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors, CLINICAL SCIENCE, Vol: 110, Pages: 37-46, ISSN: 0143-5221
- Author Web Link
- Cite
- Citations: 27
Teng QS, Garrity-Moses M, Federici T, et al., 2005, Trophic activity of Rabies G protein-pseudotyped equine infectious anemia viral vector mediated IGF-I motor neuron gene transfer in vitro, NEUROBIOLOGY OF DISEASE, Vol: 20, Pages: 694-700, ISSN: 0969-9961
- Author Web Link
- Cite
- Citations: 6
Dowd E, Monville C, Torres EM, et al., 2005, Lentivector-mediated delivery of GDNF protects complex motor functions relevant to human Parkinsonism in a rat lesion model, EUROPEAN JOURNAL OF NEUROSCIENCE, Vol: 22, Pages: 2587-2595, ISSN: 0953-816X
- Author Web Link
- Cite
- Citations: 67
Ralph GS, Mazarakis ND, Azzouz M, 2005, Therapeutic gene silencing in neurological disorders, using interfering RNA, JOURNAL OF MOLECULAR MEDICINE-JMM, Vol: 83, Pages: 413-419, ISSN: 0946-2716
- Author Web Link
- Cite
- Citations: 20
Ralph GS, Radcliffe PA, Day DM, et al., 2005, <sub>S</sub>ilencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model, NATURE MEDICINE, Vol: 11, Pages: 429-433, ISSN: 1078-8956
- Author Web Link
- Cite
- Citations: 369
Wong LF, Ralph GS, Walmsley LE, et al., 2005, Lentiviral-mediated delivery of Bcl-2 or GDNF protects against excitotoxicity in the rat hippocampus, MOLECULAR THERAPY, Vol: 11, Pages: 89-95, ISSN: 1525-0016
- Author Web Link
- Cite
- Citations: 44
Ralph Gareth S, Radcliffe Pippa A, Day Denise M, et al., 2005, Lentiviral-Mediated Silencing of Mutant SOD-1 Using RNAi Causes Long Term Correction of ALS in a Transgenic Mouse Model, Mol Ther, Vol: 11, Pages: S23-S23
Kingsman Susan M, Miskin James E, Radcliffe Pippa A, et al., 2005, Safety of In Utero Gene Delivery of Lentiviral Vectors, Mol Ther, Vol: 11, Pages: S153-S153
Wong Liang-Fong, Yip Ping K, Battaglia Anna, et al., 2005, Lentiviral Vector Expressing Retinoic Acid Receptor β2 Promotes Regeneration in a Rat Spinal Cord Injury Model Vectors, Mol Ther, Vol: 11, Pages: S251-S251
Azzouz M, Le T, Ralph GS, et al., 2004, Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy, Journal of Clinical Investigation, Vol: 114, Pages: 1726-1731, ISSN: 0021-9738
Azzouz M, Le T, Ralph GS, et al., 2004, Lentivector-mediated <i>SMN</i> replacement in a mouse model of spinal muscular atrophy, JOURNAL OF CLINICAL INVESTIGATION, Vol: 114, Pages: 1726-1731, ISSN: 0021-9738
- Author Web Link
- Cite
- Citations: 148
Miller TW, Zhou C, Gines S, et al., 2004, A human single-chain Fv intrabody preferentially targets amino-terminal huntingtin fragments in striatal models of Huntington's disease, NEUROBIOLOGY OF DISEASE, Vol: 19, Pages: 47-56, ISSN: 0969-9961
- Author Web Link
- Cite
- Citations: 41
Radcliffe BP, Cosgrave S, Mitrophanous K, et al., 2004, Reversal of hypothalamic diabetes insipidus using EIAV-based regulatable lentiviral vectors expressing arginine vasopressin, 1st Annual Conference of the British-Society-for-Gene-Therapy, Publisher: JOHN WILEY & SONS LTD, Pages: S35-S36, ISSN: 1099-498X
Azzouz M, Kingsman SM, Mazarakis ND, 2004, Lentiviral vectors for treating and modeling human CNS disorders, JOURNAL OF GENE MEDICINE, Vol: 6, Pages: 951-962, ISSN: 1099-498X
- Author Web Link
- Cite
- Citations: 56
Azzouz M, Mazarakis N, 2004, Non-primate EIAV-based lentiviral vectors as gene delivery system for motor neuron diseases, CURRENT GENE THERAPY, Vol: 4, Pages: 277-286, ISSN: 1566-5232
- Author Web Link
- Cite
- Citations: 21
Ralph S, Radcliffe PA, Bilsland L, et al., 2004, Targeted ablation of mutant SOD1 in ALS models using lentiviral mediated delivery of interfering RNA, 35th Annual Meeting of the Transactions-of-the-American-Society-for-Neurochemistry, Publisher: BLACKWELL PUBLISHING LTD, Pages: 59-59, ISSN: 0022-3042
Azzouz M, Ralph GS, Storkebaum E, et al., 2004, VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model, NATURE, Vol: 429, Pages: 413-417, ISSN: 0028-0836
- Author Web Link
- Cite
- Citations: 489
Jarraya B, Azzouz M, Miskin J, et al., 2004, Functional rescue of parkinsonian non-human primates by a dopamine producing multicistronic lentiviral vector, 7th Annual Meeting of the American-Society-of-Gene-Therapy, Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCE, Pages: S407-S407, ISSN: 1525-0016
Teng QS, Garrity-Moses M, Liu JK, et al., 2004, EIAV-IGF-I gene transfer to motor neurons enhances axonal length <i>in vitro</i>, 7th Annual Meeting of the American-Society-of-Gene-Therapy, Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCE, Pages: S280-S280, ISSN: 1525-0016
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.